Immutep Limited (ASX:IMM) Reports Promising Clinical Data
Immutep Limited (ASX:IMM) reveals promising data for HNSCC from the TACTI-003 trial, suggesting an effective therapy for underserved patients.
The Hub of Australian Finance News
Immutep Limited (ASX:IMM) reveals promising data for HNSCC from the TACTI-003 trial, suggesting an effective therapy for underserved patients.
Orthocell Limited reports first sales of Remplir™ in Singapore, ahead of schedule, highlighting a strong start for its commercialisation strategy.
Kuniko Limited (ASX:KNI) announces a significant mineral resource increase at its Ertelien project, enhancing its position in sustainable battery metal production.
X2M Connect Limited (ASX:X2M) has requested a trading halt pending an announcement regarding a capital raising.
AML3D Limited’s US technology centre is now fully operational, aiming to expand its manufacturing capabilities to meet rising Defence contract demands.
Cynata Therapeutics (ASX:CYP) has successfully treated its first patient in a kidney transplant clinical trial with CYP-001.
Top End Energy Limited (ASX:TEE) acquires a strategic natural hydrogen project in Kansas, positioning itself for substantial growth in the energy sector.
Catalyst Metals (ASX:CYL) mobilises six drill rigs to the Plutonic Gold Belt, achieving high-grade results at the Hermes project as exploration efforts expand.
Vinyl Group (ASX:VNL) has announced their acquisition of Concrete Playground for $5 million, enhancing their EBITDA and accelerating cash flow.
Buxton Resources Ltd reports significant high-grade graphite results at Graphite Bull, anticipating further resource growth.